guest ::
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
; ; ; ; ; ; ; ; ; ; ; ; ;
In
Haematologica 103(8), Seiten/Artikel-Nr.:1298-1307
2018
Online
DOI: 10.18154/RWTH-CONV-236178
DOI: 10.3324/haematol.2017.171249
URL: https://publications.rwth-aachen.de/record/750382/files/750382.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85051142821
WOS Core Collection: WOS:000440290800022
PubMed: pmid:29773593
Interne Identnummern
RWTH-CONV-236178
Datensatz-ID: 750382
Beteiligte Länder
Canada, France, Germany, Italy, South Korea, USA
; 
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF